CYTOKINETICS INCORPORATED - COMMON STOCK

Cytokinetics to Announce Fourth Quarter Results on March 1, 2023

15 фев 2023 16:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 фев 2023 16:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Recipients of Its Fifth Annual Communications Grant Program

30 янв 2023 07:30:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 янв 2023 16:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics to Participate in the 41st Annual J.P. Morgan Healthcare Conference

03 янв 2023 16:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Outcome of FDA Advisory Committee Vote On Omecamtiv Mecarbil

13 дек 2022 17:45:52 Источник Nasdaq GlobeNewswire

Cytokinetics Stock Trading Halted Today

13 дек 2022 07:02:16 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Availability of Briefing Documents for FDA Advisory Committee Meeting on Omecamtiv Mecarbil

09 дек 2022 08:59:34 Источник Nasdaq GlobeNewswire

Cytokinetics Presents Data at the Virtual 33rd International Symposium on ALS/MND

08 дек 2022 07:30:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-3828136

07 дек 2022 07:30:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 дек 2022 16:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Presentation at the Virtual 33rd International Symposium on ALS/MND

01 дек 2022 16:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Presents New Data at the American Heart Association Scientific Sessions 2022

07 ноя 2022 07:30:00 Источник Nasdaq GlobeNewswire

Cytokinetics Reports Third Quarter 2022 Financial Results

03 ноя 2022 16:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 ноя 2022 16:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Three Upcoming Presentations at the American Heart Association Scientific Sessions 2022

31 окт 2022 07:30:00 Источник Nasdaq GlobeNewswire

Cytokinetics to Announce Third Quarter Results on November 3, 2022

20 окт 2022 16:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Continuation of COURAGE-ALS Following First Interim Analysis

10 окт 2022 07:30:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 окт 2022 16:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Presents New Data From REDWOOD-HCM OLE in Late Breaking Clinical Trial Session at the HFSA Annual Scientific Meeting

02 окт 2022 09:45:00 Источник Nasdaq GlobeNewswire